Home > News > U of I targets treatment of ‘superbug’
December 7th, 2007
U of I targets treatment of ‘superbug’
Abstract:
University of Idaho researchers are working to develop more effective defenses against staphylococcus aureus bacteria and other deadly pathogens.
One of the goals of that effort, the university says, is to create faster and more accurate identification of infection strains resistant to the antibiotic methicillin. MRSA, which stands for methicillin-resistant staphylococcus aureus, is an acronym being used to refer to such so-called "superbug" strains.
Breakthrough detection technologies are already in hand at U of I labs, the university says. Nano-electronic biosensors at the university's Center for Advanced Microelectronics and Biomolecular Research (CAMBR), located in the University of Idaho Research Park, in Post Falls, recently have cut detection time for staph from the industry standard of up to three days down to three hours, researchers claim.
Source:
spokanejournal.com
Related News Press |
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||